
ACRS vs CBIO
$ACRS vs $CBIO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ACRS vs CBIO: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+4.7%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Only ACRS beat the market over the past year, by 32.4%, while CBIO trailed the S&P 500 at +4.7% by 5.1%.
- ·The last month has flipped the order: CBIO has held up better over the month (-1.1% against -10.2%) even though ACRS leads over the year.
- ·ACRS sits closer to its support, 23% above it at $2.65, while CBIO is 31.8% above its own at $8.86.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
ACRS vs CBIO: the quick read
- ·ACRS is the larger company by market cap ($546M vs $506M).
- ·ACRS has been more active on our scanner (186 vs 98 alerts in 30 days).
- ·CBIO has the smaller float (30.7M vs 151.8M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 186 and 98 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 8% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Watching ACRS or CBIO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ACRS and CBIO on TheDesperateTrader.
- Is ACRS or CBIO the better stock?
- "Better" depends on your goal, and these two are not alike. ACRS is the larger company by market cap ($546M vs $506M). ACRS has been more active on our scanner (186 vs 98 alerts in 30 days). CBIO has the smaller float (30.7M vs 151.8M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ACRS and CBIO?
- The differences that matter: they are similar in size ($546M vs $506M); they trade at very different share prices ($3.44 vs $13.00); ACRS sits at 26% of its 52-week range against 23% for CBIO; our scanner flagged ACRS 186 times in the last 30 days against 98 for CBIO. Everything above is measured from the latest completed session and SEC filings.
- Which of ACRS and CBIO is more active right now?
- Right now ACRS is at about 0.7x its normal volume and CBIO is at about 1.5x, so CBIO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is ACRS or CBIO in the stronger trend?
- ACRS is below its 50-day average of $4.21 and below its 200-day average of $4.54; CBIO is below its 50-day average of $14.10 and below its 200-day average of $16.04. They split the head-to-head evenly, 2 measures each (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ACRS or CBIO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ACRS and CBIO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.